Baton Rouge pharmaceutical firm acquiring generic drug to expand footprint south of the border

    Baton Rouge-based OncBioMune Pharmaceuticals is acquiring a generic drug that treats low blood pressure and heart failure from the Israel-based multinational pharmaceutical firm, Teva Pharmaceuticals …

    Already a subscriber? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.